Health Plan Weekly
-
MCO Stock Performance, September 2023
Here’s how major health insurers’ stock performed in September 2023. UnitedHealth Group had the highest closing stock price among major commercial insurers as of September 29, 2023, at $504.19. Humana Inc. had the highest closing stock price among major Medicare insurers at $486.52. -
News Briefs: Cigna Tucks In a New Telehealth Asset
The Cigna Group’s Evernorth division said on Oct. 10 that it acquired Bright.md, which provides “asynchronous care, triage, and health care navigation services.” The new acquisition’s capabilities will be added to Evernorth’s existing telehealth platform, MDLIVE, starting in 2024, the company said. Once the two telehealth offerings are combined, patients seeking care will be guided through a “digital clinical interview” that is then converted into a comprehensive chart note — rather than going immediately to a real-time clinician interaction. A clinician then will review the patient’s responses and offer a diagnosis, care plan or prescription, or the patient will be connected “to a different modality or setting for care when clinically appropriate.” Evernorth noted that “this asynchronous care experience is not based on artificial intelligence or machine learning, and all care decisions are made by clinicians.” Additionally, MDLIVE will expand its chronic care management to include health coaching. -
All Eyes Are on CMS After Court Reinstates Copay Accumulator Limits
On Sept. 29, a U.S. District Court ruled in favor of patient advocates who challenged a regulation that allowed most individual and group market health plans to use copay accumulator programs. So far, it isn’t clear how CMS will respond to the ruling, likely leaving health plans and PBMs waiting eagerly for guidance from the agency. But one thing is certain: Health insurers aren’t happy about the decision.
Insurers created copay accumulator programs in response to the drug manufacturer practice of offering copay assistance programs — including coupons and copay cards — to defray high out-of-pocket costs patients might face for branded drugs. When copay accumulator programs are applied, health plan enrollees are not allowed to count any direct-to-consumer discounts toward their deductibles or out-of-pocket maximums.
-
CMS, States Point Fingers Over Medicaid Redetermination Errors
Medicaid eligibility redeterminations are in full swing, but many states have struggled to fulfill automated enrollment requirements mandated by CMS, leading to finger pointing and — at a minimum — hundreds of thousands of members getting kicked off insurance rolls when they should not have been. Experts and one managed care trade group say this unfortunate state of affairs was foreseeable and could have been prevented if state Medicaid agencies had adequate staff and technical resources.
The problems with automated renewals began this spring, after a yearslong pause in eligibility checks mandated by the federal government in response to the COVID-19 pandemic. With states allowed to resume redeterminations as of April 1, millions of members who enjoyed ongoing Medicaid coverage without income eligibility checks during the COVID public health emergency are expected to be disenrolled because they now make too much money to qualify for the program. But, because of administrative reasons — most often missed paperwork sent by mail — it seems likely that many Medicaid enrollees have lost coverage even though they are still eligible, experts say.
-
What’s Driving Up ACA Premiums Next Year? Mainly, Macroeconomics
With open enrollment for Affordable Care Act exchange plans now less than a month away, a clearer picture is beginning to emerge regarding which factors are weighing the heaviest on health insurers’ minds when formulating their 2024 premium rates — as well as how much those rates are set to rise.
Based on insurers’ 2024 rate requests and their actuarial justifications, it appears that inflation is one of the biggest drivers of proposed rate increases, which states are now in the process of finalizing. However, due to expanded subsidies that have been in place since pandemic relief legislation passed, most exchange customers won’t feel the effects of rising premiums. And researchers who study the ACA exchanges tell AIS Health, a division of MMIT, that generally the individual insurance marketplace remains on solid ground — a far cry from years like 2017 and 2018 that featured significant regulatory uncertainty and major insurer exits.